Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
The report details the trend, potential and market size of Enasidenib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Enasidenibmarket, defines the market attractiveness level of Enasidenib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Enasidenib industry, describes the types of Enasidenib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Enasidenib market and the development prospects and opportunities of Enasidenib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Enasidenib market in Chapter 13.
By Player:
Celgene Corporation
By Type:
50mg
100mg
By End-User:
Hospital
Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Enasidenib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Enasidenib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Enasidenib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Enasidenib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Enasidenib Market Analysis and Outlook to 2022
-
7.1 Global Enasidenib Consumption (2017-2022)
-
7.2 United States Enasidenib Consumption (2017-2022)
-
7.3 Europe Enasidenib Consumption (2017-2022)
-
7.4 China Enasidenib Consumption (2017-2022)
-
7.5 Japan Enasidenib Consumption (2017-2022)
-
7.6 India Enasidenib Consumption (2017-2022)
-
7.7 South Korea Enasidenib Consumption (2017-2022)
8 Region and Country-wise Enasidenib Market Analysis and Outlook to 2028
-
8.1 Global Enasidenib Consumption Forecast (2022-2028)
-
8.2 United States Enasidenib Consumption Forecast (2022-2028)
-
8.3 Europe Enasidenib Consumption Forecast (2022-2028)
-
8.4 China Enasidenib Consumption Forecast (2022-2028)
-
8.5 Japan Enasidenib Consumption Forecast (2022-2028)
-
8.6 India Enasidenib Consumption Forecast (2022-2028)
-
8.7 South Korea Enasidenib Consumption Forecast (2022-2028)
9 Global Enasidenib Market Outlook by Types and Applications to 2022
-
9.1 Global Enasidenib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 50mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 100mg Consumption and Growth Rate (2017-2022)
-
9.2 Global Enasidenib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Enasidenib Market Outlook by Types and Applications to 2028
-
10.1 Global Enasidenib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 50mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 100mg Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Enasidenib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Enasidenib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Enasidenib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Enasidenib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Enasidenib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Enasidenib Market Competitive Analysis
-
14.1 Celgene Corporation
-
14.1.1 Celgene Corporation Company Details
-
14.1.2 Celgene Corporation Enasidenib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Celgene Corporation Enasidenib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Enasidenib
-
Figure Enasidenib Picture
-
Table Global Enasidenib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Enasidenib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Enasidenib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Enasidenib Consumption by Country (2017-2022)
-
Figure United States Enasidenib Consumption and Growth Rate (2017-2022)
-
Table Europe Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure China Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Japan Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure India Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Global Enasidenib Consumption Forecast by Country (2022-2028)
-
Figure United States Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 50mg Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global 50mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Enasidenib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Enasidenib Export by Region (Top 5 Countries) (2017-2028)
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Enasidenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Enasidenib Product and Service
-
